Estadístiques de Gal-1 expression analysis in the GLIOCAT multicenter study: Role as a prognostic factor and an immune-suppressive biomarker
Visites totals
| views | |
|---|---|
| Gal-1 expression analysis in the GLIOCAT multicenter study: Role as a prognostic factor and an immune-suppressive biomarker | 63 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Martinez_cel_gal.pdf | 83 |
| Martinez_cel_gal.pdf(legacy) | 18 |
Vistes principals per país
| views | |
|---|---|
| United States | 37 |
| Belgium | 6 |
| Spain | 6 |
| Ireland | 5 |
| Brazil | 2 |
| Germany | 2 |
| Australia | 1 |
| Canada | 1 |
| Côte d’Ivoire | 1 |
| South Korea | 1 |
| Sweden | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Fairfield | 6 |
| Dublin | 5 |
| San Ramon | 5 |
| Menlo Park | 4 |
| Barcelona | 3 |
| Cambridge | 3 |
| Mountain View | 3 |
| Andover | 2 |
| Boardman | 2 |
| Pamplona | 2 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Fredericton | 1 |
| Fremont | 1 |
| Rochester | 1 |
| Vitoria | 1 |